Home / Newsletter

Know first when something changes.

Once a month — one new study, one patient story, and a digest from the world of M35.4. Under 5 minutes to read. No spam. No ads.

Join ~240 people already reading.

/ I am

patient doctor / specialist family member researcher other

/ e-mail address

Unsubscribe in one click. Always.

/ latest issue — #05 · 02.05.2026

Methotrexate vs mycophenolate mofetil — what do the first data from a multicentre study show? What criteria qualify a patient for second-line treatment and when is it worth discussing a regimen change with a rheumatologist.

Full issue archive ↓

First Saturday of the month · Once a month

One research paper

We translate one PubMed article — no jargon, with conclusions for the patient and the doctor.

II.

A story or voice from the community

A patient, doctor, or translator — someone living or working with M35.4 shares something concrete.

III.

Literature digest

What's new in the literature? DOI, link to PDF where open access.

IV.

One practical tip

Daily life with M35.4 — sleep, rehab, work, how to talk to your doctor.

~240

subscribers

68%

open rate

issues

ads

/ archive

Previous issues

Every issue stays in the archive — you can read everything before deciding whether to subscribe.

Issue 05

02.05.2026 · Clinical trialsSecond-line treatment

Methotrexate vs mycophenolate — early data from a multicentre study

Issue 04

04.04.2026 · DiagnosticsSymptoms

Groove sign — the symptom to show your doctor on the first visit

Issue 03

07.03.2026 · Patient storyCommunity

Hans from Germany: four drugs and three years searching for a regimen

/ privacy

Zero tracking.

No tracking pixels, no Google Analytics, no address reselling. Your e-mail is used solely to send the newsletter.

/ frequency

One e-mail per month.

Always the first Saturday morning of the month. Never more than once a month — even if something important happens, it waits until the next first Saturday.

/ unsubscribe

One click.

The unsubscribe link is in the footer of every issue. No confirmation, no 'why are you leaving' surveys, no 5 steps. One click.